Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target with 26.92% Profit: QuantWave Forecast Success

June 30, 2023
ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, resulting in a profit of 26.92%. The forecast signal was issued on April 19, 2023, with the stock price at $364.28 and predicted direction as long. The target price was reached on June 30, 2023, at $462.34, showcasing the accuracy and effectiveness of QuantWave's analytics.

Market analysis reveals that ELI LILLY AND COMPANY has experienced significant movements in recent months, driven by factors such as strong financial performance, product pipeline updates, and industry trends. The successful forecast by QuantWave underscores the platform's ability to provide valuable insights for investors seeking profitable opportunities in the market.

QuantWave is an automated forecasting platform that offers predictions for a wide range of stocks, empowering users with the potential for financial gains. For those interested in delving deeper into investment strategies, QuantSchool provides comprehensive educational resources to guide individuals in utilizing the QuantWave forecasting system effectively and achieving consistent income.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

GEJune 6, 2025QuantWave Successfully Hits 40.62% Profit Target for GE AEROSPACE Stock Forecast  ~1 min.

QuantWave, the automated forecasting platform, has achieved a significant milestone by accurately predicting a 40.62% profit for its forecast on GE AEROSPACE stock....

LIJuly 28, 2023LI AUTO INC. Hits Price Target Forecast with 35.66% Profit: QuantWave Analysis  ~1 min.

QuantWave, the automated forecasting platform, has once again proven its predictive power with the successful achievement of a price target forecast for LI AUTO INC....

XOMSeptember 27, 2023EXXON MOBIL CORPORATION Hits Price Target Forecast with 11.19% Profit  ~1 min.

On August 22, 2023, QuantWave's automated forecasting platform issued a long signal for EXXON MOBIL CORPORATION, with a price of $101.73....

LUMNApril 4, 2025QuantWave Achieves 32.85% Profit Target on LUMEN TECHNOLOGIES, INC. Stock Forecast  ~1 min.

QuantWave, an automated forecasting platform, successfully reached its price target forecast for LUMEN TECHNOLOGIES, INC. with a 32.85% profit margin....

CSCOJune 5, 2025QuantWave Achieves 13.98% Profit in Forecast for Cisco Systems, Inc.  ~1 min.

QuantWave, an automated forecasting platform, successfully reached its price target forecast for Cisco Systems, Inc. on June 5, 2025....